Tolvaptan
Tolvaptan is a selective vasopressin receptor antagonist utilised in managing specific complex medical processes within the body. The primary formulation available in our directory is Samsca. This active compound addresses serious electrolyte disturbances and chronic organ conditions, and we currently list 1 available formulation for patients to review.
Key points
- A selective vasopressin V2-receptor antagonist that blocks water retention signals in the kidney, increasing water excreted in urine without major electrolyte loss.
- Used to correct hyponatraemia and to slow cyst growth in autosomal dominant polycystic kidney disease.
- Increased thirst and frequent urination are expected as it raises fluid loss, and blood sodium levels need monitoring during treatment.
What is Tolvaptan?
Tolvaptan is a medicine that acts on the kidneys to regulate how the body manages water balance. It is classified as an aquaretic agent, which means it promotes the excretion of free water without the significant loss of electrolytes. Because it interacts with specific physiological pathways, it is sometimes categorised within broader discussions of medical management like Hormone Therapy.
What Tolvaptan is used for
This medication is primarily used to address specific health conditions requiring precise fluid regulation. Clinicians may use it to manage Hyponatraemia, a state where sodium levels in the blood are abnormally low. It is also utilised to address the progression of Autosomal Dominant Polycystic Kidney Disease, helping to slow the growth of cysts or reduce kidney volume in specific clinical contexts.
How does Tolvaptan work?
Tolvaptan works by blocking the action of arginine vasopressin at specific receptors in the kidneys. These receptors, known as V2-receptors, are responsible for signalling the kidneys to retain water. By inhibiting this signal, the medicine effectively increases the amount of water excreted in urine. This mechanism helps to raise sodium levels in the blood and prevent the further enlargement of cysts in kidney disease.
Tolvaptan brands and forms
The medicine is primarily available as the brand Samsca, which is administered as an oral tablet. Different strengths may be available to allow for careful titration by a medical professional. Because the medication requires specific physiological monitoring, clinicians focus on selecting the correct tablet dosage based on the severity of the condition and the patient’s individual response.
Safety overview for Tolvaptan
What to check before using this medicine
Review your complete medical history with a doctor, especially if you have liver disease or conditions affecting your ability to excrete urine. Inform your healthcare provider of all other medications you take, as some substances may interact with how this medication moves through your body.
Possible reactions and tolerability
Common experiences during treatment may include increased thirst, frequent urination, or dry mouth. These reactions occur because the medication increases the volume of water excreted. Some individuals may experience changes in blood sodium levels, which require monitoring.
Interactions and health factors
Certain medications, particularly those affecting the liver or those that are strong enzyme inhibitors, can change the concentration of this compound in your system. Product labelling and verified clinical sources remain the correct references for specific contraindications, interactions and reactions.